Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is hemangioblastoma?
A hemangioblastoma is a benign (non-cancerous) tumor made up of a dense tangle of small blood vessels. It almost always grows in the central nervous system — most often in the cerebellum (the part of the brain at the back of the head that controls balance and coordination), but also in the brainstem and spinal cord. Although it is not cancer and does not spread to other organs, it matters because of where it grows: even a small tumor in these delicate areas can press on vital structures or block the flow of spinal fluid, causing headaches, balance problems, weakness, or numbness. Many hemangioblastomas also have a fluid-filled cyst attached to them, and it is often the cyst, expanding over time, that produces symptoms. A defining feature is the tumor's rich blood supply, which both gives it a characteristic appearance on scans and makes surgery technically demanding. Hemangioblastomas come in two settings. Most are sporadic — a single tumor in someone with no underlying condition — and removing it usually cures the problem. But about a quarter to a third occur as part of an inherited condition called von Hippel-Lindau (VHL) disease, in which people develop multiple hemangioblastomas over their lifetime along with tumors and cysts in other organs such as the kidneys, adrenal glands, and pancreas. Because of this, finding a hemangioblastoma — especially more than one, or one at a young age — should prompt a conversation about genetic testing and screening for the rest of the body. Treatment centers on surgery when the tumor is causing symptoms and can be safely reached, with focused radiation (radiosurgery) for tumors that are deep, multiple, or otherwise difficult to remove.
The main types
Doctors group hemangioblastoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Cerebellar hemangioblastoma | The most common location, at the back of the brain; often has an associated cyst and is usually curable with surgery when symptomatic. |
| Spinal cord hemangioblastoma | Grows within or on the spinal cord, where it can cause pain, weakness, or numbness; treated with microsurgery or focused radiation depending on location. |
| Brainstem hemangioblastoma | A tumor in the brainstem, where surgery is riskier; radiosurgery is often favored to control it while protecting vital functions. |
| Sporadic (single) hemangioblastoma | A lone tumor in someone without VHL disease; complete removal is generally curative. |
| VHL-associated (multiple) hemangioblastomas | Several tumors arising as part of von Hippel-Lindau disease; managed over a lifetime with surveillance, selective surgery, and radiosurgery, plus screening of other organs. |
Staging, in plain terms
Hemangioblastomas are benign and do not spread, so they are not given a cancer stage. What guides treatment instead is a practical description of the tumor: where it sits (cerebellum, brainstem, or spinal cord), how big it is, whether it has an attached cyst that is enlarging, and whether it is producing symptoms. A small, silent tumor found incidentally may simply be watched with periodic MRI scans, while one causing headaches, imbalance, or nerve problems calls for treatment. An equally important part of the assessment is determining whether the tumor is sporadic — a single tumor with no underlying condition — or part of von Hippel-Lindau (VHL) disease. This distinction changes everything about long-term care: a person with VHL will be monitored for new hemangioblastomas throughout life and screened for tumors and cysts in the kidneys, adrenal glands, pancreas, inner ear, and eyes, and their relatives may be offered genetic testing. Multiple tumors, a tumor at a young age, or a family history all raise suspicion for VHL and prompt genetic evaluation. So rather than a stage, the framework here is location and symptoms (to decide if and how to treat) combined with a genetic context (to decide how closely to watch the rest of the body).
| No formal cancer stage — a benign tumor described by location, size, cyst, symptoms, and whether it is sporadic or part of VHL disease | What it generally means |
|---|---|
| Incidental / asymptomatic | A small tumor found by chance that is causing no problems; usually monitored with periodic MRI rather than treated right away. |
| Symptomatic, resectable | A tumor causing symptoms that can be safely reached; surgery to remove it is generally curative. |
| Symptomatic, difficult location | A tumor in the brainstem, deep, or in a delicate spot where surgery is risky; focused radiosurgery is often used to control it. |
| VHL-associated, multiple | Several tumors as part of von Hippel-Lindau disease; managed over time with surveillance, selective surgery or radiosurgery, and whole-body screening. |
The standard of care
Hemangioblastoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgical removal
The main treatment for a symptomatic, accessible hemangioblastoma; complete removal is usually curative, though the tumor's rich blood supply makes the operation technically demanding.
Stereotactic radiosurgery (SRS)
Highly focused radiation that controls tumors which are deep, near the brainstem, multiple, or otherwise hard to remove — sparing the patient an open operation.
Active surveillance
Small, symptom-free tumors, especially in VHL disease, are watched with regular MRI and treated only if they grow or cause problems.
Genetic testing and VHL screening
Because many hemangioblastomas are part of von Hippel-Lindau disease, testing and lifelong screening of the eyes, kidneys, adrenal glands, pancreas, and inner ear are key parts of care.
Targeted therapy in VHL (belzutifan)
For VHL disease, an oral medicine that blocks the abnormal HIF-2 pathway can shrink hemangioblastomas and other VHL tumors, offering an option when surgery or radiation aren't ideal.
How radiation treatment works
Radiation therapy treats hemangioblastomas by delivering precisely focused energy that damages the tumor cells and, over time, the abnormal blood vessels that make up the tumor, halting its growth. Because hemangioblastomas are benign and do not spread, the goal of radiation is local control — stopping a specific tumor from enlarging and causing pressure on the brain, brainstem, or spinal cord — rather than treating the whole body. The treatment of choice for a symptomatic, reachable tumor is surgery, which can be curative. Radiation steps in when an operation is too risky or impractical: tumors deep in the brainstem, tumors wrapped around delicate structures, or the multiple tumors that develop in people with von Hippel-Lindau disease, where repeated open surgeries would be undesirable. The main technique is stereotactic radiosurgery, which concentrates a high, sharply defined dose on the tumor in one or a few sessions while sparing the surrounding normal tissue; for tumors next to especially sensitive areas the dose can instead be divided over several treatments, and for spinal tumors a focused spinal radiation approach is used. The benefit of radiation builds gradually over months to a couple of years as the tumor's blood vessels close down and it stops growing or slowly shrinks. One nuance is that the cyst frequently attached to a hemangioblastoma may respond more slowly than the solid tumor, and surgery remains better when a large cyst is the main source of symptoms. For people with VHL disease, radiosurgery is especially valuable because it allows several tumors to be controlled over a lifetime with minimal disruption, and it is increasingly combined with newer targeted medicines that shrink VHL tumors throughout the body. Used in the right situations, focused radiation offers durable control of these tumors while protecting the precious surrounding tissue.
The main ways radiation is delivered for hemangioblastoma:
Stereotactic radiosurgery (SRS)
Delivers a high, precisely shaped dose to the tumor in one or a few sessions, controlling growth while sparing the surrounding brain or spinal cord — ideal for small, deep, brainstem, or multiple tumors.
Fractionated stereotactic radiotherapy
Spreads focused radiation over several treatments for tumors close to especially sensitive structures, lowering the dose to nearby healthy tissue per session.
Spinal stereotactic body radiation (SBRT)
Focused radiation to a spinal cord hemangioblastoma that can't be safely removed, giving durable control while respecting the cord's dose limits.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Radiosurgery gives durable control of hemangioblastomas: Long-term series of stereotactic radiosurgery for brain and spinal hemangioblastomas report high rates of tumor control over many years, supporting it as an effective alternative when surgery is risky or for multiple tumors in VHL disease.[1]
Hemangioblastoma radiosurgery outcome studies
Targeted therapy shrinks VHL-related tumors: The HIF-2 inhibitor belzutifan reduced the size of hemangioblastomas, kidney tumors, and pancreatic tumors in people with von Hippel-Lindau disease, providing a systemic option that can delay or avoid surgery and radiation.[2]
Belzutifan von Hippel-Lindau disease trial
Surveillance is appropriate for silent tumors: Studies show that small, asymptomatic hemangioblastomas — particularly in VHL disease — can be safely watched with serial MRI and treated only when they grow or cause symptoms, avoiding unnecessary intervention.[3]
VHL hemangioblastoma surveillance cohorts
Common questions
Is a hemangioblastoma cancer? No. A hemangioblastoma is a benign tumor — it is not cancer and does not spread to other organs. It matters because of where it grows: in the brain, brainstem, or spinal cord, where even a small tumor or its attached cyst can press on important structures and cause symptoms. Treatment is aimed at controlling that one tumor, not at fighting a spreading disease.
Why might I be tested for von Hippel-Lindau disease? Because a sizable share of hemangioblastomas — especially when there is more than one, when they appear at a young age, or when there's a family history — are part of an inherited condition called VHL disease. Diagnosing VHL matters because it means watching for new tumors over time and screening other organs such as the kidneys, adrenal glands, pancreas, and eyes, and offering testing to relatives.
When is radiation used instead of surgery? Surgery is the first choice for a symptomatic tumor that can be safely reached, and it is often curative. Focused radiation (stereotactic radiosurgery) is preferred when a tumor is deep, in the brainstem, or one of several tumors in VHL disease, where repeated operations would be undesirable. Radiation controls the tumor gradually over months while protecting the surrounding brain and spinal cord.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.